PEAK6 Investments’s OptimizeRx OPRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-12,100
Closed -$173K 4550
2023
Q4
$173K Sell
12,100
-19,300
-61% -$185K ﹤0.01% 3329
2023
Q3
$244K Buy
31,400
+30,200
+2,517% +$329K ﹤0.01% 2939
2023
Q2
$17.1K Sell
1,200
-56,800
-98% -$809K ﹤0.01% 3604
2023
Q1
$849K Buy
58,000
+53,500
+1,189% +$895K ﹤0.01% 1970
2022
Q4
$75.6K Sell
4,500
-14,800
-77% -$256K ﹤0.01% 3776
2022
Q3
$286K Sell
19,300
-146,700
-88% -$2.9M ﹤0.01% 3381
2022
Q2
$4.53M Sell
166,000
-44,000
-21% -$1.3M 0.01% 1458
2022
Q1
$7.92M Sell
210,000
-162,400
-44% -$7.19M 0.02% 817
2021
Q4
$23.1M Sell
372,400
-319,400
-46% -$24.2M 0.05% 372
2021
Q3
$59.2M Buy
691,800
+657,300
+1,905% +$41.2M 0.13% 122
2021
Q2
$2.14M Buy
34,500
+27,100
+366% +$1.38M 0.01% 1845
2021
Q1
$361K Buy
+7,400
New +$357K ﹤0.01% 3480
2020
Q3
Sell
-23,500
Closed -$306K 4737
2020
Q2
$306K Buy
+23,500
New +$255K ﹤0.01% 3072
2019
Q4
Sell
-30,000
Closed -$434K 3865
2019
Q3
$434K Buy
+30,000
New +$464K ﹤0.01% 2384

Other funds holding OPRX

PEAK6 Investments's OPRX Position: Q4 2023 in Review

PEAK6 Investments sold out of OptimizeRx (OPRX) in Q4 2023, closing a stake of 5,925 shares — an estimated $56.9K sold.

PEAK6 Investments first reported a position in OPRX in Q3 2019 and held it in 10 quarters. The position peaked at $3.37M in Q1 2022. 98 funds tracked by Wall St. Rank hold OPRX as of Q4 2023.

  • PEAK6 Investments reported no remaining OptimizeRx position as of Q4 2023 after selling out during the quarter.
  • PEAK6 Investments sold 5,925 OptimizeRx shares in Q4 2023, an estimated $56.9K.
  • PEAK6 Investments first reported a position in OptimizeRx in Q3 2019 and held it in 10 quarters.
  • PEAK6 Investments's OptimizeRx position peaked at $3.37M in Q1 2022.
  • 98 funds tracked by Wall St. Rank held OptimizeRx as of Q4 2023.

Based on PEAK6 Investments's 13F filing for Q4 2023, filed 13 Feb 2024.